Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Read More
Optimizing Care for Orphan Diseases With Pulmonary Issues During COVID-19 Pandemic
April 5th 2022The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.
Read More
Clinical Overview: Opzelura for Atopic Dermatitis
April 5th 2022Ruxolitinib (Opzelura; Incyte) is a Janus kinase inhibitor indicated for patients 12 years of age or older whose atopic dermatitis is inadequately controlled with topical prescription therapies or when those therapies are inappropriate.
Read More
FDA Approves Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma
April 4th 2022Axicabtagene ciloleucel (Yescarta) approved for patients with large B-cell lymphoma that is refractory to first-line chemoimmunotherapy or relapses within 12 months of first-line chemoimmunotherapy.
Read More